Endothelial to mesenchymal transition (EndMT) and arterial remodelling in IPF patients

M. Eapen (Launceston (TAS), Australia), A. Gaikwad (Launceston (TAS), Australia), P. Bhattarai (Launceston (TAS), Australia), S. Dey (Launceston (TAS), Australia), C. Chia (Launceston (TAS), Australia), J. Larby (Launceston (TAS), Australia), G. Haug (Launceston (TAS), Australia), J. Jaffar (Melbourne (Vic), Australia), G. Westall (Melbourne (Vic), Australia), G. Singhera (Vancouver (BC), Canada), T. Hackett (Vancouver (BC), Canada), W. Lu (Launceston (TAS), Australia), S. Sohal (Launceston (TAS), Australia)

Source: International Congress 2022 – New mechanistic insights into acute and chronic interstitial lung disorders

Session: New mechanistic insights into acute and chronic interstitial lung disorders
Session type: Thematic Poster
Number: 2793

Rating:

You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Eapen (Launceston (TAS), Australia), A. Gaikwad (Launceston (TAS), Australia), P. Bhattarai (Launceston (TAS), Australia), S. Dey (Launceston (TAS), Australia), C. Chia (Launceston (TAS), Australia), J. Larby (Launceston (TAS), Australia), G. Haug (Launceston (TAS), Australia), J. Jaffar (Melbourne (Vic), Australia), G. Westall (Melbourne (Vic), Australia), G. Singhera (Vancouver (BC), Canada), T. Hackett (Vancouver (BC), Canada), W. Lu (Launceston (TAS), Australia), S. Sohal (Launceston (TAS), Australia). Endothelial to mesenchymal transition (EndMT) and arterial remodelling in IPF patients. 2793

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.

You must Login to comment this presentation.